VEN in combination with 10-day DEC in newly diagnosed elderly or relapsed/refractory acute myeloid leukemia, and high-risk myelodysplastic syndrome: long term follow-up of a phase 2 trial. - Swaminathan M; DiNardo CD; Maiti A; Pemmaraju N; Ohanian M; Daver NG; Garcia-Manero G; Issa GC; Borthakur G; Ravandi F; Montalban-Bravo G; Kadia TM; et al. (Blood cancer journal, 2025)